Press releases

Cats and dogs could be passing on superbugs to their owners

Swabs collected from hospitalised people found microbes shared with pets at home showing same antibiotic resistance however, risk of cross-infection is low.

 

Click here to read the article in The Gaurdian

 

Click here to read the article in The Telegraph

 

People Are Far Less Likely to Get Long COVID After Omicron, Study Finds

Researchers still have a lot to learn about Long COVID—when symptoms linger long after a COVID-19 infection is over—but new data suggest there may be some good news for people infected with the virus more recently.

 

Click here to read the article in TIME

 

Study shows those infected with COVID early in the pandemic were 40% less likely than those who were not to get COVID-19 during the first six months of Omicron activity

Infection with the original first-wave SARS-CoV-2 virus during March to September 2020 was associated with a 40% reduction in the risk of infection during the omicron BA.1/BA.2 period from December 2021–May 2022. COVID-19 vaccination conferred additional protection, and our study showed younger individuals to be more at risk of infection by omicron than older age groups.

 

Click here to read the article (Medical Express)

 

Study finds ‘classic triad’ of meningitis symptoms rare in both children and adults

Children and adults with meningitis typically have just one of the “classic triad” of symptoms, a study shows.Symptoms experienced can also differ between child and adult patients.

 

Click here to read the article (The Sun)

 

Click here to read the article (US Times Post)

 

Avoiding a global chocolate disaster – how tracing and recalls avoided a worldwide Salmonella outbreak

Largest ever recall of chocolate products in global history, just before Easter, prevented thousands of extra cases.

 

Click here to read the article (Irish Independent)

 

Click here to read the article (Wales Online)

 

More than 100 years after the first TB vaccine, why are we still waiting for a second?

It has been more than 100 years since the first and only tuberculosis (TB) vaccine—the Bacillus Calmette–Guérin (BCG) vaccine—was used for the first time medically in 1921. In a presentation in one of the preliminary pre-ECCMID days of this year's European Congress on Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, April 15-19) Frank Cobelens, Professor of Global Health at the University of Amsterdam and the Amsterdam Institute for Global Health and Development (AIGHD), Netherlands, will discuss the frontrunners among the candidate vaccines, and the challenges facing TB vaccine development.

 

Click here to read the article (Medical Express)

 

Click here to read the article (IFL Science)

 

FDA vaccine panel to consider annual COVID shots: What we know

The agency is proposing an annual COVID-19 booster shot that is matched to circulating strains and offered in the fall for most Americans.

 

Click here to read the article (USA Today)

 

Click here to read the article (US News & World Report)

 

Click here to read the article (WebMD)